COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges

Abstract

With the major spread of SARS-COV-2 around the world, its association with various pathologies has been reported. However, hemopathy has rarely been revealed during a coronavirus infection. The authors of this article aim to emphasize the diagnostic and therapeutic challenges faced while treating COVID/hemopathy patients.

Keywords

• covid-19
• sars-cov-2
• cll
• diagnosis
• therapy